申请人:Clunas Scott
公开号:US20110300074A1
公开(公告)日:2011-12-08
This invention pertains generally to processes, uses, methods and materials utilising particular xanthylium compounds, including compounds of formula (I) and (II), as further defined herein. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease.
本发明涉及一般涉及利用特定的黄色素化合物的过程、用途、方法和材料,包括公式(I)和(II)所定义的化合物。这些化合物可用作药物,例如,在治疗tau病理学疾病,如阿尔茨海默病方面有用。